Document is current
Any future updates will be listed below
-
Authors
Ma, Feiyang https://orcid.org/0000-0002-6260-0787
Plazyo, Olesya
Billi, Allison C.
Tsoi, Lam C.
Xing, Xianying
Wasikowski, Rachael https://orcid.org/0000-0003-3544-3023
Gharaee-Kermani, Mehrnaz
Hile, Grace
Jiang, Yanyun
Harms, Paul W. https://orcid.org/0000-0002-0802-2883
Xing, Enze https://orcid.org/0000-0001-9358-9368
Kirma, Joseph
Xi, Jingyue
Hsu, Jer-En
Sarkar, Mrinal K. https://orcid.org/0000-0001-8505-4259
Chung, Yutein
Di Domizio, Jeremy https://orcid.org/0000-0002-6281-3918
Gilliet, Michel https://orcid.org/0000-0002-4609-3762
Ward, Nicole L. https://orcid.org/0000-0003-1907-2621
Maverakis, Emanual https://orcid.org/0000-0002-6294-6294
Klechevsky, Eynav https://orcid.org/0000-0001-6121-1571
Voorhees, John J. https://orcid.org/0000-0003-1856-785X
Elder, James T. https://orcid.org/0000-0003-4215-3294
Lee, Jun Hee https://orcid.org/0000-0002-2200-6011
Kahlenberg, J. Michelle https://orcid.org/0000-0002-4006-8945
Pellegrini, Matteo
Modlin, Robert L. https://orcid.org/0000-0003-4720-031X
Gudjonsson, Johann E. https://orcid.org/0000-0002-0080-0812
- License Information
-
More Information
Article History
Received: 11 January 2022
Accepted: 26 May 2023
First Online: 12 June 2023
Competing interests
: J.E.G. has received research support from Almirall, AnaptysBio, Novartis, AbbVie, Eli Lilly, Kyowa Kirin, Galderma, BMS, Janssen. J.E.G. has served as advisor to Pfizer, AbbVie, Eli Lilly, Galderma, Almirall, AnaptysBio, Novartis, Sanofi, BMS. J.M.K. has received research support from Janssen, BMS, and Q32 bio. J.M.K. has served as an advisor to Eli Lilly, BMS, AstraZeneca, GlaxoSmithKline, Ventus Therapeutics, Admirex Pharmaceuticals, Aurinia Pharmaceuticals, and Provention Bio. The remaining authors declare no competing interests.
